Diatide sees rosy future as it prepares to launch its first product
This article was originally published in Clinica
Executive Summary
Diatide is about to launch its first product, AcuTect, a peptide-based imaging agent to detect acute venous thrombosis in the legs and thighs. The product is expected to carry the US company through to profitability by 2000, as Karen Beynon reports.